UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 31, 2006
Biogen Idec Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
0-19311
|
|
33-0112644 |
(State or other jurisdiction
of incorporation)
|
|
(Commission
file number)
|
|
(IRS Employer
Identification No.) |
| |
|
|
|
|
14 Cambridge Center, Cambridge, Massachusetts
|
|
02142 |
(Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code (617) 679-2000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition.
On October 31, 2006, the registrant issued a press release announcing its unaudited results of
operations and financial condition for the three months ended September 30, 2006. A copy of the
press release is furnished as Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On October 31, 2006, the registrant posted presentation slides on its corporate website in
connection with an earnings conference and webcast. A copy of the presentation is furnished as
Exhibit 99.2.
Item 9.01 Financial Statements and Exhibits.
The press release and presentation slides are being furnished pursuant to Item 2.02 and Item
7.01 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities
of that Section, nor shall such document be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Exchange Act.
99.1 Registrant’s press release dated October 31, 2006.
99.2 Registrant’s presentation dated October 31, 2006.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
|
Biogen Idec Inc. |
|
|
|
|
|
|
|
By: |
|
/s/ Daniel S. Char |
|
|
|
|
|
|
|
|
|
Daniel S. Char |
|
|
|
|
Associate General Counsel and |
|
|
|
|
Assistant Secretary |
Date: October 31, 2006 |
|
|
|
|